Results of Multiple Linear Regression. by Benjamin S. Killen (22766029)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Linear regression analysis. by Young Kyu Lee (14076058)

Subjects:

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

“…Changes during drug infusion were compared in a linear mixed model to assess the effects of s-ketamine and midazolam compared to saline. …”

Spatiotemporal Gait Parameters Across Terrains. by Benjamin S. Killen (22766029)

Subjects:

Participant Demographic Information. by Benjamin S. Killen (22766029)

Subjects:

Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average ste... by Benjamin S. Killen (22766029)

Subjects:

A summary of the included study characteristics. by Zahra Tajik (20752452)

Subjects:

Table1_Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease.docx by Jiahong Yi (14481735)

“…LTL decreased all-cause mortality especially for patients older than 65 years or men. …”

Distribution of Patient-centered care scores as a function of Time. by Thales Guardia de Barros (22216025)

Subjects:

Boxplot of Patient-centered care scores as a function of Time. by Thales Guardia de Barros (22216025)

Subjects:

The results of linear mixed model. by Soheila Qanbari (20455173)

Subjects:

Patient demographics. by Yongwoo Lee (2265172)

“…When the vertical distribution was analyzed by further subdivision into six equal parts from top to bottom, the average difference in LLT decreased in the uppermost segment after treatment.…”

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

Subjects:

Difference in (a) IL-17, and (b) TNF-α relative gene expression levels between baseline and six months after treatment using systemic and local antibiotic treatment. by Iva Milinkovic (22331710)

Subjects:

Participants enrollment. by Chikondi Maluwa (20660522)

Subjects:

KAP assessment scores (n = 422). by Chikondi Maluwa (20660522)

Subjects:

The demographic details of the six patients. by Xiao Long (3191091)

List of Included studies. by Zahra Tajik (20752452)

Subjects: